T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Genesco
GCO
$394M
| $318K | ﹤0.01% |
14,932
+540
| +4% | +$18.8K |
|
|
SHYF
2427
DELISTED
The Shyft Group
SHYF
| $318K | ﹤0.01% |
39,221
+5,463
| +16% | +$58.6K |
|
2428
Titan Machinery
TITN
$420M
| $318K | ﹤0.01% |
18,604
+3,949
| +27% | +$65.2K |
|
|
AVDL
2429
DELISTED
Avadel Pharmaceuticals
AVDL
| $316K | ﹤0.01% |
40,350
+3,677
| +10% | +$30.8K |
|
2430
Douglas Elliman
DOUG
$183M
| $316K | ﹤0.01% |
183,604
| – | – |
|
2431
Community Health Systems
CYH
$419M
| $315K | ﹤0.01% |
116,308
+6,321
| +6% | +$19.7K |
|
2432
NovaGold Resources
NG
$3.4B
| $315K | ﹤0.01% |
107,574
+13,156
| +14% | +$42.3K |
|
2433
Northrim BanCorp
NRIM
$601M
| $315K | ﹤0.01% |
17,208
+484
| +3% | +$9.59K |
|
2434
Astronics
ATRO
$4.57B
| $313K | ﹤0.01% |
15,529
+1,644
| +12% | +$27.6K |
|
2435
Bowman Consulting
BWMN
$731M
| $313K | ﹤0.01% |
14,303
| – | – |
|
2436
Intellia Therapeutics
NTLA
$1.66B
| $313K | ﹤0.01% |
43,906
+4,611
| +12% | +$46.6K |
|
|
UDMY
2437
DELISTED
Udemy
UDMY
| $313K | ﹤0.01% |
40,270
+4,206
| +12% | +$35.8K |
|
|
SAGE
2438
DELISTED
Sage Therapeutics
SAGE
| $312K | ﹤0.01% |
39,167
-375,054
| -91% | -$2.75M |
|
2439
American Vanguard Corp
AVD
$62.8M
| $311K | ﹤0.01% |
70,549
+640
| +0.9% | +$3.27K |
|
2440
FLEX LNG
FLNG
$1.64B
| $311K | ﹤0.01% |
13,502
+1,276
| +10% | +$30.5K |
|
|
PVBC
2441
DELISTED
Provident Bancorp
PVBC
| $311K | ﹤0.01% |
27,060
+330
| +1% | +$3.86K |
|
2442
Aehr Test Systems
AEHR
$4.02B
| $310K | ﹤0.01% |
42,416
+17,700
| +72% | +$196K |
|
2443
NB Bancorp
NBBK
$1B
| $309K | ﹤0.01% |
17,092
+2,060
| +14% | +$38.3K |
|
2444
Pacific Biosciences
PACB
$357M
| $308K | ﹤0.01% |
260,841
-1,510,812
| -85% | -$2.32M |
|
2445
E.W. Scripps
SSP
$310M
| $307K | ﹤0.01% |
103,553
-8,001
| -7% | -$17.5K |
|
2446
Digimarc Corp
DMRC
$158M
| $306K | ﹤0.01% |
23,807
+5,961
| +33% | +$170K |
|
2447
Transcat
TRNS
$888M
| $304K | ﹤0.01% |
4,079
+512
| +14% | +$42.9K |
|
2448
Energy Fuels
UUUU
$3.64B
| $303K | ﹤0.01% |
80,972
+7,794
| +11% | +$37.4K |
|
2449
Shutterstock
SSTK
$217M
| $302K | ﹤0.01% |
16,202
+3,747
| +30% | +$96K |
|
|
AAMI
2450
Acadian Asset Management
AAMI
$3.31B
| $302K | ﹤0.01% |
11,674
+1,015
| +10% | +$25.5K |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.